Stay updated on Nivolumab in Resectable NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.

Latest updates to the Nivolumab in Resectable NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision: v3.4.2 was added, and Revision: v3.4.1 along with a government funding status notice were removed. These are housekeeping updates that do not affect the study details or trial information.SummaryDifference0.3%

- Check30 days agoChange DetectedIntroduced a government funding lapse notice on the page and updated the revision tag from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check37 days agoChange DetectedThe page gains a glossary toggle and updated metadata fields (Last Update Submitted that Met QC Criteria, Last Update Posted) along with a new revision tag (v3.4.0), while related older metadata items are removed. These changes pertain to navigation/maintenance rather than study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check51 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. The new revision is now displayed in place of the previous version.SummaryDifference0.0%

- Check72 days agoChange DetectedLocations section added with Maryland, New York, Washington, and Quebec sites; the older location blocks were removed and the page revision updated to v3.3.3.SummaryDifference0.4%

- Check87 days agoChange DetectedTimestamp-related fields such as 'Last Update Posted (Estimated)' and recent dates (e.g., 2025-11-17, 2025-11) were updated. No changes were made to the study content, arms, or eligibility criteria.SummaryDifference0.2%

Stay in the know with updates to Nivolumab in Resectable NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.